A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.
about
The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside.Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?Dynamic contrast-enhanced MRI for oncology drug development.Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.Dosimetry and first human experience with 89Zr-panitumumabQuantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges.Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
P2860
Q33588163-A50C78DC-D4DA-42B7-9275-B5D79EE2AD5FQ38652294-058CE9AC-0BE5-4ED1-BFC8-01A603D74557Q38672966-B65C2BD0-47C6-45B0-A8A1-71D45925BA57Q38725827-95207B64-4D6D-4409-A9AE-4E83FC7097D1Q38941928-6547099F-3239-4938-9B0D-AA3CC03B5CBEQ41180495-D778D528-5AD9-446C-9777-BDF927080325Q52904949-7656AC68-AD16-404F-949E-6D8330186EA2Q58806326-B0B300BF-A9E4-47FB-AE97-CDB2F2ADBC4F
P2860
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@en
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@nl
type
label
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@en
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@nl
prefLabel
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@en
A Phase II Study of Sorafenib ...... Metastatic Colorectal Cancer.
@nl
P2093
P1476
A Phase II Study of Sorafenib ...... d Metastatic Colorectal Cancer
@en
P2093
Baris Turkbey
Beata Holkova
Cody J Peer
Erin Larkins
James H Doroshow
John J Wright
Maria L Lindenberg
Mark Raffeld
P304
P356
10.1016/J.CLCC.2015.02.007
P407
P50
P577
2015-03-07T00:00:00Z